Stirnadel-Farrant, Heide A. http://orcid.org/0000-0003-0734-0422
Luo, Jiacong
Kler, Lata
Cizman, Borut
Jones, Delyth
Brunelli, Steven M.
Cobitz, Alexander R.
Funding for this research was provided by:
GlaxoSmithKline
Article History
Received: 30 January 2018
Accepted: 22 May 2018
First Online: 11 June 2018
Ethics approval and consent to participate
: We used pre-existing, de-identified data. According to 45 CFR part 46 from the United States Department of Health and Human Services this study was exempt from institutional review board approval. We adhered to the Declaration of Helsinki; informed consent was not required. The study was deemed exempt by an Institutional Review Board (Quorum IRB, Seattle, WA).
: HAS, LK, BC, DJ, and ARC are employees of and own stock in GlaxoSmithKline. JL and SMB are employees of DaVita Clinical Research. SMB’s spouse is an employee of AstraZeneca. This study was sponsored by GlaxoSmithKline.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.